A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Conditions
- Obesity
- Overweight and/or Obesity
- Knee Osteoarthritis
- Diabetes Melliuts, Type 2
Interventions
- DRUG: Berobenatide
- DRUG: Placebo
Sponsor
Pfizer